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Abstract
Background and objectives
In high-risk populations, the efficacy of mesh placement in incisional hernia (IH) prevention after
elective abdominal surgeries has been supported by many published studies. This meta-analysis
aimed at providing comprehensive and updated clinical implications of prophylactic mesh placement
(PMP) for the prevention of IH as compared to primary suture closure (PSC).
Materials and methods
PubMed, Science Direct, Cochrane, and Google Scholar were systematically searched until March 3,
2020, for studies comparing the efficacy of PMP to PSC in abdominal surgeries. The main outcome of
interest was the incidence of IH at different follow-up durations. All statistical analyses were carried
out using Review Manager version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration,
2014) and Stata 11.0 (Stata Corporation LP, College Station, TX). The data were pooled using the
random-effects model, and odds ratio (OR) and weighted mean differences (WMD) were calculated
with the corresponding 95% confidence interval (CI).
Results
A total of 3,330 were identified initially and after duplicate removal and exclusion based on title and
abstract, 26 studies comprising 3,000 patients, were included. The incidence of IH was significantly
reduced for PMP at follow-up periods of one year (OR= 0.16 [0.05, 0.51]; p=0.002; I2=77%), two years
(OR= 0.23 [0.12, 0.45]; p<0.0001; I2=68%), three years (OR= 0.30 [0.16, 0.59]; p=0.0004; I2= 52%), and
five years (OR=0.15 [0.03, 0.85]; p=0.03; I2=87%). However, PMP was associated with an increased risk
of seroma (OR=1.67 [1.10, 2.55]; p= 0.02; I2=19%) and chronic wound pain (OR=1.71 [1.03, 2.83]; p=
0.04; I2= 0%). No significant difference between the PMP and PSC groups was noted for postoperative
hematoma (OR= 1.04 [0.43, 2.50]; p=0.92; I2=0%), surgical site infection (OR=1.09 [0.78, 1.52]; p= 0.62;
I2=12%), wound dehiscence (OR=0.69 [0.30, 1.62]; p=0.40; I 2= 0%), gastrointestinal complications
(OR= 1.40 [0.76, 2.58]; p=0.28; I2= 0%), length of hospital stay (WMD= -0.49 [-1.45, 0.48]; p=0.32;
I2=0%), and operating time (WMD=9.18 [-7.17, 25.54]; p= 0.27; I2=80%).
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Conclusions
PMP has been effective in reducing the rate of IH in the high-risk population at all time intervals, but
it is associated with an increased risk of seroma and chronic wound pain. The benefits of mesh largely
outweigh the risk, and it is linked with positive outcomes in high-risk patients.
Categories: Preventive Medicine, General Surgery, Quality Improvement
Keywords: incisional hernia, mesh placement, suture, chronic wound pain, seroma, prophylactic mesh use,
high-risk, abdominal surgery, laparotomy, laparoscopic surgery
Introduction
Any procedure that requires access to the abdominal wall carries with itself the precarious
complication of incisional hernia (IH). This is especially common in patients undergoing open
bariatric surgery and abdominal aneurysm repair. The incidence of IH is approximately 11%-20% in
patients post laparotomy, but it can be as high as 39.9% in high-risk populations such as obesity, prior
abdominal operation, abdominal aortic aneurysm, or patients suffering from neoplastic diseases [1-4].
Annually, 150,000 patients are operated for IH in the United States alone, with one-third repairs
occurring within nine years. IH not only creates a financial burden but also leads to poor health-
related quality of life (QoL) in patients. It is also associated with poor body image and a lower sense of
self-worth [2,5-6].
Mesh placement has been found effective in reducing occurrences of umbilical hernia, inguinal
hernia, and parastomal hernia. Previous systematic reviews have also yielded supportive findings
regarding the efficacy of prophylactic mesh placement (PMP) in preventing IH [4,7-8]. However, they
did not evaluate the time-based effectiveness of PMP as compared to primary suture closure (PSC) and
did not study the differences among various population subgroups, as they were limited by small
sample size. Furthermore, the literature remains inconclusive on whether the mesh is efficacious in
reducing chronic wound pain [8].
Due to the lack of sufficient quality evidence, there is a need for further high-quality studies to
support the use of mesh for IH prevention in high-risk patients [8]. Several new studies have been
published since the last meta-analysis, and therefore, we sought to conduct an updated meta-analysis
of all studies to date. The larger sample size enabled us to provide a holistic, well-powered assessment
of the efficacy of a prophylactic mesh in preventing IH. One of the reasons why the efficacy of a
prophylactic mesh has remained unclear is maybe because of varying effectiveness in different patient
subgroups. Hence, we also aimed to conduct a range of subgroup analyses to identify specific patient
populations in which a prophylactic mesh might be beneficial. Additionally, we sought to evaluate
seldom-evaluated aspects of mesh placement, including hematoma, seroma, chronic wound pain,
surgical site infections, gastrointestinal complications, operating time, and length of hospital stay.
Materials And Methods
The current study has been carried out in accordance with the Preferred Reporting Items for Systemic
Reviews and Meta-analysis (PRISMA) guidelines. Two independent reviewers carried out the
literature search, quality assessment, data extraction, and statistical analyses. In case of any conflict,
a third reviewer was consulted.
Search strategy
Online databases, including PubMed, Science Direct, and CENTRAL Register of Controlled Trials
(Cochrane), were systematically searched from the inception of databases till March 3, 2020, without
time or language restrictions. Google Scholar was also searched for gray literature. References of
relevant reviews were also manually searched for additional studies. The search strategy for each
database is given in Table 1.
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Online
databases Search strategy
PubMed
((((((mesh[tiab] OR prosthe*[tiab] OR implant*[tiab]))) AND ((prophyla*[tiab] OR prevent*[tiab]))) AND herni*[tiab]) AND
((incision*[tiab] OR postoperat*[tiab] OR laparotomy[tiab] OR laparoscopy*[tiab] OR surger*[tiab] OR surgic*[tiab] OR operation*
[tiab] OR operative*[tiab] OR ventral*[tiab] OR transverse*[tiab] OR abdom*[tiab])))
Google
Scholar
incisional hernia AND prophylactic AND mesh repair OR mesh placement AND midline laparotomy OR laparoscopic surgery
AND suture closure
Cochrane prophylactic AND mesh AND incisional hernia
Science
Direct
incisional hernia AND prophylactic AND mesh repair OR mesh placement AND midline laparotomy AND laparoscopic surgery
AND suture closure
TABLE 1: Search strategy for online databases
Study selection
All the studies were imported into EndNote Reference Library version X4 (Clarivate Analytics,
Thomson Reuters Corporation, Philadelphia, Pennsylvania), and duplicates were screened and
removed. Randomized controlled trials (RCTs) and observational studies encompassing all patients
>18 years undergoing an elective laparotomy or laparoscopic procedure and ≥ 1 risk factor for
incisional hernia (prior abdominal operation, neoplastic disease, history of abdominal aortic
aneurysm, ≥45 years of age, body mass index (BMI) ≥25 kg/m2, smoking, and chronic obstructive
pulmonary disease history) were included.
Exclusion criteria included primary or prior surgery for hernia or existing abdominal mesh, emergency
cases, life expectancy <24 months, and pre-existing pregnancy. Studies without a control group and
all procedures done for mesh placement in stoma sites were excluded as well. Only elective cases were
considered and studies reporting emergency surgeries were excluded.
Data extraction and outcomes
Information regarding study characteristics, demographics, and reported outcomes were extracted.
Four different mesh locations were considered: (1) Onlay position (above the anterior rectus sheath or
below the abdominal fascia); (2) Retrorectus, also known as the sublay position (between the rectus
abdominis muscle and posterior rectus sheath); (3) Preperitoneal (between the posterior rectus sheath
and parietal peritoneum), and (4) Intraperitoneal (in the abdominal cavity).
The main outcome of interest was the incidence of IH at different follow-up durations. Other
outcomes included seroma, chronic wound pain, hematoma, wound dehiscence, surgical site
infection, respiratory and gastrointestinal complications, hospital stay, and operating time. The
incidence of IH was confirmed by clinical examination or imaging modalities, such as ultrasonography
or computed tomography (CT) scan, and no difference was made between IH diagnosed clinically or
through imaging modalities. Gastrointestinal complications included ascites, bowel obstruction,
bowel perforation, intra-abdominal abscess, and paralytic ileus. We accepted the primary study
investigator’s definition for seroma and all remaining outcomes.
The number of patients that presented during follow-up was considered as the denominator instead
of randomization numbers for meta-analyses of outcomes. Studies were classified in each follow-up
group based on follow-up time. Where specific follow-up was not mentioned, mean or median follow-
up was used to classify the study. Study characteristics and early complications were extracted from
earlier publications of a trial if publication of the latest follow-up data lacked them. The incidence of
2020 Ahmed et al. Cureus 12(9): e10491. DOI 10.7759/cureus.10491 3 of 37
IH was recorded from each follow-up duration. Studies that did not provide means and standard
deviations (SD) for hospital stay duration and operation time were not included in the respective
analysis.
Statistical analysis
Review Manager v.5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014) and Stata 11.0
(Stata Corporation LP, College Station, TX) were used for all statistical analyses.
Patients’ data were divided into two groups - PSC or PMP - according to the procedure. Weighted
mean differences (WMD) and Mantel-Haenszel (MH) odds ratios (OR) were calculated with a 95%
confidence interval (CI) and pooled using a random-effects model. Subgroup analyses were performed
by stratifying studies according to study design (RCT and observational), mesh location (onlay,
retrorectus, preperitoneal, and intraperitoneal), BMI (<40 and >40), and study population (bariatric,
neoplastic, vascular, and mixed). The chi-squared test (p-interaction) was used to assess subgroup
differences.
Statistical heterogeneity was quantified across studies using Higgin's I2 statistics, and a value of 25%-
50% was considered mild, 50%-75% as moderate, and >75% as severe. The leave one out analysis was
performed to determine whether any single study had a disproportionate effect on the pooled results.
Quality assessment
The quality assessment of studies was done using the Cochrane Collaboration risk-of-bias tool and
the Newcastle-Ottawa scale for RCTs and observational studies, respectively. Publication bias was
assessed using a funnel plot and Egger’s regression test. A p-value of ≤ 0.05 was considered
significant in all cases.
Results
A total of 3,330 records were identified in the initial search, 3,319 from electronic databases and 11
through references of relevant studies (other sources). After removing duplicates and excluding
articles based on title and abstract screening, the full texts of 73 articles were reviewed for
eligibility. A total of 26 articles met the inclusion criteria [1-3,5,9-29]. Figure 1 shows the PRISMA
flowchart summarizing the literature search.
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FIGURE 1: PRISMA flow diagram for literature search
PRISMA, Preferred Reporting Items for Systemic Reviews and Meta-Analysis
The follow-up time in the included studies ranged from six to 60 months. Out of the 26 studies, 17
were RCTs and nine were observational (seven prospective cohorts and two retrospective studies).
The included studies enrolled a total of 3,349 participants, from which 3,000 were analyzed (1,397
receiving PMP and 1,603 receiving PSC). The rest were either lost to follow-up or excluded during
surgery. Study characteristics and demographics are given in Table 2.
Study; Year;
Location; Study
design
Study
population
Total no. of patients; Males
(%); Age in years (SD); BMI in
kg/m2
Type of Incision &
surgery Cohort N
No. of
IH (%)
Incidence
reporting
MESH NO MESH
2020 Ahmed et al. Cureus 12(9): e10491. DOI 10.7759/cureus.10491 5 of 37
Pans, 1998 [9];
Belgium; RCT Bariatric
144; 41 (28.4);
36.6 (0.9); 43.8
(0.5)
144; 30 (20.8);
36.4 (0.9);
43.7(0.6)
Midline incision; Open
bariatric surgery
PSC 144 41
(28.5)
0-67
months
(mean
follow-up
was 29.8)
PMP -
intraperitoneal 144
33
(22.9)
Strzeczyk, 2002
[10]; Poland;
Prospective
Bariatric 12 (mesh) vs 48 (non-mesh); 37(61.7); 37.3 (11.2); 45.1 (7.2).
Midline incision; Open
Roux-en-Y gastric
bypass surgery
PSC 48 9(18.8) 12 months
PMP - onlay 12 0 (0.0)
Peña, 2003 [11];
Spain; RCT
Neoplastic
and high risk
50 (mesh) and 50 (non-mesh);
67 (67); 64.3 (42-83).
Medial and paramedial
incision; Laparotomy
PSC 44 5(11.4)
36 months
PMP - onlay 44 0(0.00)
Strzelczyk, 2006
[12]; Poland; RCT Bariatric
37; 24 (66.7);
39.4(12.3);
46.2 (7.1)
40; 23 (60.5);
38.9(11.8);
46.8(7.6)
Midline incision; Open
Roux-en-Y gastric
bypass surgery
PSC 38 8(21.1)
6-38
months
(mean 28
months)
PMP -
retrorectus 36 0 (0.0)
El- Khadrawy,
2009 [1]; Egypt;
RCT
Bariatric
20; 8 (40);
47.86 (13.82);
9 (45%) obese
20; 10 (50);
47.61 (14.11);
8 (40) obese
Midline incisions;
Abdominal operation
PSC 20 3 (15)
36 monthsPMP -
preperitoneal 20 1 (5)
Bevis, 2010 [13];
UK; RCT
Abdominal
aortic
aneurysm
40; 34 (85); 74
(59-84)
45: 43 (95.5);
72 (59-89)
Midline incision; Open
abdominal aortic
aneurysm repair
PSC 43 16(37.2) 36 months
(mean
follow-up
26)
PMP -
retrorectus,
preperitoneal
37 5(13.5)
Llaguna, 2011
[14]; USA;
Prospective
Bariatric
59; 13 (29.55);
43.73 (11.81);
52.58 (10.59
75; 10 (16.13);
39.39 (11.08);
50.38 (9.31)
Midline incision; Open
Roux-en-Y gastric
bypass surgery
PSC 62 11(17.7)
24 months
PMP -
preperitoneal 44 1 (2.3)
Curro, 2012* [15];
Italy; Prospective Bariatric
45; 7 (15.5); 38
(27-64); 45
(40-60)
50; 9 (18); 39
(23-66); 46(40-
65)
Midline incision; Open
biliopancreatic
diversion
PSC 50 15 (30)
12 and 24
monthsPMP -
retrorectus 45 2 (4.4)
Abo-Ryia, 2013
[16]; Egypt; RCT Bariatric
32; 6 (18.7);
38.5 (10.8);
52.2 (9.1)
32; 7 (21.8);
36.9 (11.3);
51.4 (10.5)
Midline incision; Open
bariatric surgery
PSC 32 9(28.1) 6, 12,18
and 24
monthsPMP -
preperitoneal 32 1 (3.1)
Armañanzas,
2014 [17]; Spain;
RCT
Symptomatic
cholelithiasis
and high risk
53; 11(24.4);
60.3 (16.2);
30.5 (6.1)
53; 9 (19.1);
61.9 (15.3);
30.6 (5.3)
Laparoscopic
cholecystectomy
PSC 47 15(31.9) 24 hours
and 12
monthsPMP -
intraperitoneal 45 2 (4.4)
Sarr, 2014 [18];
USA; RCT Bariatric
199; 39 (21);
44.6(10.6);
203; 39 (20);
45.1 (12.1);
Midline incision; Open
Roux-en-Y gastric
bypass surgery
PSC 195 38(19.5) 6, 12 and
24 months
PMP - 32
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48.2 98.2) 48.2(7.7) preperitoneal 185 (17.3)
Bali, 2015 [19];
Greece; RCT
Abdominal
aortic
aneurysm
20; 18 (90); 75;
25.4
20; 18 (90); 75;
24.4
Midline incision; Open
abdominal aortic
aneurysm repair
PSC 20 6 (30)
36 months
PMP - onlay 20 0 (0.0)
Muysoms, 2016
[20]; Belgium;
RCT
Abdominal
aortic
aneurysm
56; 54 (96); 72
(7.4); 25 (3.6)
58; 51 (88); 72
(8.5); 26 (3.7)
Midline incision; Open
abdominal aortic
aneurysm repair
PSC 58 16(27.6) 12 and 24
monthsPMP -
retrorectus 56 0 (0.0)
Blázquez, 2016
[21]; Spain;
Prospective
Neoplastic
58; 35 (60.3);
62.59 (11);
27.33 (5.68)
57; 35 (61.4);
61.96 (12);
28.35 (5.40)
Bilateral subcostal
incisions; Abdominal
operations
PSC 57 10(17.54)
24 months
PMP - onlay 58 1(1.72)
Jairam, 2017* [5];
Netherlands,
Germany, and
Austria; RCT
Abdominal
Aortic
Aneurysm
PSC- 107; 68 (64); 65.2 (10.5);
29.8 (4.4)
Midline incision; Open
abdominal aortic
aneurysm repair
PSC 107 33 (30)
24 monthsOnlay mesh- 188; (62); 64.2(12.3); 30.8 (5.9) PMP- onlay 188 25 (13)
Retrorectus mesh – 185; (58);
64.4 (10.4); 30.8 (5.2)
PMP -
retrorectus 185 34 (18)
Hoyuela, 2017
[22]; Spain;
Prospective
Neoplastic
15; 10 (66.7);
76.4 (11); 27.8
(2)
37; 23 (62.2);
71 (11); 28.9
(2)
Laparoscopic colon
resection
PSC 37 4(10.8) 18 months
PMP - onlay 15 0 (0.0)
Kohler, 2018 [23];
Switzerland; RCT
Neoplastic or
high risk
83; 46 (66.7);
67 (58-72);
27.6 (4.6)
86; 56 (69.1);
65 (56.5-70);
26.7 (4.8)
Midline or transverse
incision; Open
abdominal surgery
PSC 81 15(18.5)
36 months
PMP-
intraperitoneal 69 5 (7.2)
Argudo, 2018 [24];
Spain;
Prospective
Neoplastic 226; 138 (61); 77 (11) Midline incision; Openabdominal surgery
PSC 114 36(31.6)
12- 60
months
(mean 32
months)PMP - onlay 112 9 (8)
Pereira, 2018 [25];
Spain;
Retrospective
Neoplastic
Midline Incision without mesh-
61; 40 (65.6); 69.3 (12.5); 26.6
(4.4)
Midline or transverse
incision; Laparoscopic
colon and rectal
resection
PSC - midline
incision (no
mesh)
61 20(32.8)
Up to 20
months
(median
13
months)
Transverse incision- 87; 50
(57.5); 68.8 (11.8); 26.3 (4.2)
PSC -
transverse
incision
87 16(18.4)
Midline incision with mesh-34;
17 (50); 72.4 (10.9); 30.2 (5.6) PMP - onlay 34 3 (8.8)
Rhemtulla, 2018
[6]; USA;
Retrospective
High risk 18; 8 (44.4);54.3; 29.5
75; 35 (46.7);
58.2; 29.5
Midline incision;
Abdominal laparotomy
PSC 75 4 (5.3)
6 months
PMP - onlay 18 0 (0.0)
Glauser, 2019*
[2]; Switzerland; High risk
131; 60 (45.8);
64.1 (61.9-
136; 56 (41.2);
65.1 (63.1- Midline incision;
Abdominal
PSC 88
46
(52.3) 24 and 60
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RCT 66.4); 25.8
(25.0-26.7)
67.1); 26.6
(25.8-27.4)
surgery/laparotomy PMP -
intraperitoneal 95
26
(27.4)
months
Caro‑Tarrago,
2019* [3]; Spain;
RCT
Neoplastic
80; 44 (55);
64.32 (14.27);
>30 (26.3)
80; 46 (57.5);
67.32 (11.11);
>30 (30.1)
Midline incision;
Abdominal
surgery/laparotomy
PSC 80 37(46.8) 12 and 60
months
PMP - onlay 80 4 (5.1)
TABLE 2: Baseline characteristics and demographics of included studies
PSC, primary suture closure; PMP, prophylactic mesh placement; IH, incisional hernia; RCT, randomized controlled trial; BMI, body mass index
* These studies have longer duration results published separately [26-29]; thus 22 studies are shown in this table. In studies where multiple
follow-up intervals are reported, only the incidence of IH at the latest follow-up is shown.
Mesh, suture, and surgery details
In all except four studies, patients underwent midline laparotomy. In three studies, laparoscopic
surgery was done, and in one study, patients underwent bilateral subcostal incisions [17,21-22,25]. A
variety of meshes were used in the studies, with polypropylene (PP) being the most common one
(n=11 studies). Three studies used different biologic meshes, i.e., Alloderm, Surgisis Gold, and Bovine
pericardium [14,18-19]. One study used an unspecified biosynthetic mesh [6]. Other meshes used
included, but were not limited to, polyglactin, propylene polyglycolic acid, and polypropylene-
polyvinylidene fluoride. Meshes were placed in four different locations. Two studies planted mesh in
two separate locations [5,13]. Nine studies placed the mesh in the onlay position. The most commonly
used technique in studies for aponeurosis closure was continuous. The diagnostic modalities for IH,
mesh, and suture details for included studies are summarized in the Appendices section.
Quality assessment and publication bias
The majority of the RCTs and observational studies were of robust methodological quality. Half of the
RCTs either had a high or unclear risk of bias in the blinding of participants and personnel (Figure 2).
Details of bias assessment in observational studies are present in Table 3. The funnel plot showed
significant publication bias (Figure 3), and it was confirmed by Egger’s regression test (p=0.031).
FIGURE 2: Assessment of publication bias in randomized
controlled trials using the Cochrane Collaboration risk-of-bias tool
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Author,
year
Selection Comparability Outcome
Total
score
Representativeness
of the exposed
cohort
Selection
of non-
exposed
cohort
Ascertainment
of exposure
Demonstration
that outcome
was not
present at the
beginning
Comparability
of groups 
Assessment
of outcome
Was
follow up
long
enough
for
outcomes
to occur?
Adequacy
of follow
up of
cohorts
 High-risk population High-riskpopulation
Surgery
record on
databases
Surgery
record on
databases
- Blinded andindependent
≥6
months ≥90%  
Curro,
2012 [15] 1 1 1 1 1 0 1 1 7
Llaguna,
2011 [14] 1 1 1 1 1 0 1 0 6
Strzeczyk,
2002 [10] 1 1 1 1 1 0 1 1 7
Argudo,
2018 [24] 1 1 1 1 1 1 1 1 8
Pereira,
2018 [25] 1 1 1 1 1 1 1 1 8
Blázquez-
Hernando,
2016 [21]
1 1 1 1 1 1 1 1 8
Hoyuela,
2017 [22] 1 1 1 1 1 1 1 1 8
Rhemtulla,
2018 [6] 1 1 1 1 1 1 1 1 8
TABLE 3: Quality assessment of observational studies included in the meta-analysis using
the New-Castle Ottawa scale
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FIGURE 3: Funnel plot for publication bias
Funnel plot is based on the two-year incisional hernia outcome follow-up.
SE, standard error; OR, odds ratio
Results of meta-analyses
The summarized results of all outcomes discussed below are given in Figure 4. Individual outcomes
with their forest plots are given under their respective subheadings. A table summarizing the effects
of the leave one out analysis for each outcome is given in the appendices section.
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FIGURE 4: Forest plot summarizing the results of all the meta-
analyses
CC, complication; CI, confidence interval; IV, inverse variance; M-H, Mantel-Haenszel; PMP, prophylactic
mesh placement; PSC, primary suture closure; SSI, surgical site infection
Incidence of IH at six months
Three studies (PMP - 235 patients, 13 events; PSC - 302 patients, 15 events) mentioned IH occurrence
at the six-months follow-up. No significant difference was found between the PMP and PSC groups
(OR=1.17 [0.52, 2.61]; p=0.71; I2=0%). The leave one out analysis did not reveal any single study,
which had a disproportionate effect on the results.
There was no significant difference in the incidence of IH between subgroups when data was
stratified according to (1) Study design (p-interaction=0.49; I2=0%), (2) Mesh location (p-
interaction=0.49; I2=0%), (3) BMI (p-interaction=0.49; I2=0%), or (4) Study population (p-
interaction=0.49; I2=0%) as shown in Figure 5.
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FIGURE 5: Incisional hernia at six months
(A) Overall analysis; (B) Subgroups by study design; (C) Subgroups by mesh location; (D) Subgroups by
BMI; and (E) Subgroups by population
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PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analyses include [6,16,18].
Incidence of IH at one year
A total of eight studies (PMP - 469 patients, 37 events; PSC - 633 patients, 141 events) reported IH
incidence at the one-year follow-up. PMP significantly reduced the incidence of IH when compared to
PSC (OR=0.16 [0.05, 0.51]; p=0.002; I2=77%). Sensitivity analysis did not reveal any disproportionate
effects. Notably, however, heterogeneity (I2) dropped to 0% on removing the Sarr, 2014, study.
No significant difference was found between subgroups upon stratifying data according to (1) Study
design (p-interaction=0.70; I2=0%), (2) Mesh location (p-interaction=0.28; I 2=21.1%), (3) BMI (p-
interaction=0.11; I2=60.2%), and (4) Study population (p-interaction=0.58; I2=0%).
It was noted that upon subgroup analysis by the study population, PMP significantly reduced the IH
risk in all study populations except bariatric (OR=0.30 [0.07, 1.36]; p=0.12; I2=63%). All forest plots are
given in Figure 6.
2020 Ahmed et al. Cureus 12(9): e10491. DOI 10.7759/cureus.10491 13 of 37
FIGURE 6: Incisional hernia at one year
(A) Overall analysis; (B) Subgroups by study design; (C) Subgroups by mesh location; (D) Subgroups by
BMI; and (E) Subgroups by population
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PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analyses include [10,15-18,20,25,29].
Table 4 highlights the different subgroups analysis carried out for IH at the six-month and one-year
follow-ups.
Subgroups IH at 6-months follow-up IH at 1-year follow-up
 Nstudies
I2
(%)
OR [95% CI] Psubgroup Comments
N
studies
I2
(%)
OR [95% CI] Psubgroup Comments
Study design
RCT 2 0 1.26 [0.55,2.91]
0.49 No Sig.Diff.
5 86 0.14 [0.03,0.82]
0.70 No Sig.Diff.
Observational 1 - 0.43 [0.02,8.34] 3 0
0.21 [0.08,
0.59]
Mesh location
Onlay 1 - 0.43 [0.02,8.34]
0.49 No Sig.Diff.
3 50 0.13 [0.03,0.52]
0.28 No Sig.Diff.
Retrorectus - - - 2 0 0.07 [0.01,0.38]
Preperitoneal 2 0 1.26 [0.55,2.91] 2 59
0.60 [0.11,
3.14]
Intraperitoneal - - - 1 - 0.10 [0.02,0.47]
Mean BMI
<40 1 - 0.43 [0.02,8.34]
0.49 No Sig.Diff.
2 0 0.08 [0.02,0.32]
0.11 No Sig.Diff.
>40 2 0 1.26 [0.55,2.91] 5 60
0.33 [0.11,
1.00]
Study population
Bariatric 2 0 1.26 [0.55,2.91]
0.49 No Sig.Diff.
4 63 0.30 [0.07,1.36]
0.58 No Sig.Diff.
Neoplastic - - - 2 75 0.12 [0.02,0.81]
Vascular - - - 1 - 0.04 [0.00,0.72]
Mixed 1 - 0.43 [0.02,8.34] 1 -
0.10 [0.02,
0.47]
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TABLE 4: Results of subgroup analyses for IH at the six-month and one-year follow-ups
All outcomes are stratified according to study design (RCTs or observational), mesh location (onlay, retrorectus, preperitoneal, and
intraperitoneal), mean BMI (<40 and >40), and study population (bariatric, neoplastic, vascular, and mixed). The value of I2 shows the
heterogeneity among subgroups.
Psubgroup represents p-values between subgroups.
IH, incisional hernia; OR, odds ratio; No Sig. Diff., no significant difference; Sig. Diff., Significant difference.
Incidence of IH at 18 months
Two studies (PMP- 47 patients, 1 events; PSC- 69 patients, 12 events) reported incidence of IH at 18-
months. Meta-analysis (Figure 7) demonstrated significant reduction of IH in the PMP group
(OR=0.13 [0.02, 0.75]; p=0.02; I2=0%).
FIGURE 7: Incisional hernia at 18 months
PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analysis include [16,22].
Incidence of IH at two years
IH incidence was reported by nine studies (PMP-936 patients, 114 events; PSC - 702 patients, 180
events) at the two-year follow-up. PMP significantly reduced the incidence in comparison to PSC
(OR=0.23 [0.12, 0.45]; p<0.0001; I2=68%). Heterogeneity turned insignificant after removal of Sarr,
2014 study (new I2=47%; p=0.07). Leave one out analysis did not affect results.
No significant differences were noted in the following subgroups: (1) Study design (p-
interaction=0.08; I2=67.2%), (2) Mesh location (p-interaction=0.77; I2=0%), (3) BMI (p-
interaction=0.57; I2=0%), and (4) Study population (p-interaction=0.55; I2=0%).
Upon subgroup analysis by mesh location, however, all mesh locations except preperitoneal (OR=0.25
[0.04-1.52]; p=0.13; I2=75%) were found to reduce the risk of IH significantly. Subgroup analysis by
study population showed that all populations except vascular (OR=0.13 [0.01, 2.76]; p=0.19; I2=78%)
had a significant reduction in IH incidence after PMP. These findings are seen in Figure 8.
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FIGURE 8: Incisional hernia at two years
(A) Overall analysis; (B) Subgroups by study design; (C) Subgroups by mesh location; (D) Subgroups by
BMI; and (E) Subgroups by population
2020 Ahmed et al. Cureus 12(9): e10491. DOI 10.7759/cureus.10491 17 of 37
PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analyses include [5,12,14,16,18,20-21,25,28].
Incidence of IH at three years
Seven studies (PMP - 446 patients, 53 events; PSC - 466 patients, 122 events) reported the incidence
of IH at three years. Mesh placement significantly decreased the IH incidence (OR=0.30 [0.16, 0.59];
p=0.0004; I2=52%). Sensitivity analysis by excluding individual studies kept results significant and
robust. Heterogeneity (p=0.05) turned insignificant (p=0.80) and dropped to 0% after the removal of
the Pans, 1998, study.
Upon subgroup analysis, no significant difference was found among: (1) Study design (p-
interaction=0.21; I2=36.4%), and (2) BMI (p-interaction=0.15; I2=51.4%).
On grouping data by mesh location and study population, a significant difference was seen between
subgroups (p-interaction=0.05 and 0.02, respectively). While both PMP in the onlay position (OR=0.17
[0.08, 0.35]; p<0.00001; I2=0%) as well as the intraperitoneal position (OR=0.59 [0.29, 1.19]; p=0.14;
I2=39%) reduced IH, performance in the onlay position was significantly better (p-interaction=0.02).
All populations except bariatric (OR=0.71 [0.43, 1.20]; p=0.20; I2=0%) showed significant reduction in
IH incidence at the three-years follow-up after PMP. Individual forest plots for all analyses are given
in Figure 9.
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FIGURE 9: Incisional hernia at three years
(A) Overall analysis; (B) Subgroups by study design; (C) Subgroups by mesh location; (D) Subgroups by
BMI; and (E) Subgroups by population
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PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analyses include [1,9,11,13,19,23-24].
The different subgroups analyses carried out for IH at the two-year and three-year follow-up are given
in Table 5.
Subgroups IH at 2-years follow-up IH at 3-year follow-up
 Nstudies
I2
(%)
OR [95% CI] Psubgroup Comments
N
studies
I2
(%)
OR [95% CI] Psubgroup Comments
Study design
RCT 6 70 0.32 [0.15,0.66]
0.08 No Sig.Diff.
6 37 0.37 [0.19,0.73]
0.21 No Sig.Diff.
Observational 3 0 0.10 [0.03,0.29] 1 -
0.19 [0.09,
0.42]
Mesh location
Onlay 2 42 0.24 [0.07,0.83]
0.77 No Sig.Diff.
3 0 0.17 [0.08,0.35]
0.05† Sig. Diff.
Retrorectus 4 71 0.13 [0.03,0.63] - - -
Preperitoneal 3 75 0.25 [0.04,1.52] 1 -
0.30 [0.03,
3.15]
Intraperitoneal 1 - 0.32 [0.17,0.61] 2 39
0.59 [0.29,
1.19]
Mean BMI
<40 4 55 0.27 [0.13,0.56]
0.57 No Sig.Diff.
2 27 0.23 [0.05,1.05]
0.15 No Sig.Diff.
>40 5 75 0.17 [0.04,0.71] 1 -
0.75 [0.44,
1.27]
Study population
Bariatric 5 75 0.17 [0.04,0.71]
0.55 No Sig.Diff.
2 0 0.71 [0.43,1.20]
0.02†† Sig. Diff.
Neoplastic 1 - 0.08 [0.01,0.67] 1 -
0.19 [0.09,
0.42]
Vascular 2 78 0.13 [0.01,2.76] 2 0
0.22 [0.08,
0.62]
Mixed 1 - 0.32 [0.17,0.61] 2 0
0.29 [0.11,
0.79]
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TABLE 5: Results of subgroup analyses for IH at the two-year and three-year follow-ups
All outcomes are stratified according to study design (RCTs or observational), mesh location (onlay, retrorectus, preperitoneal, and
intraperitoneal), mean BMI (<40 and >40), and study population (bariatric, neoplastic, vascular, and mixed). The value of I2 shows the
heterogeneity among subgroups.
Psubgroup represents p-values between subgroups.
IH, incisional hernia; No Sig. Diff., no significant difference; Sig. Diff, Significant difference
 † - Significant difference was found only between onlay and intraperitoneal mesh (p=0.02). †† - Neoplastic group has a significantly lower
incidence of IH than the bariatric group (p=0.006).
Incidence of IH at five years
Follow-up at five years was reported in two studies (PMP - 175 patients, 30 events; PSC - 168
patients, 83 events), and pooled results significantly favored PMP (OR=0.15 [0.03, 0.85]; p=0.03;
I2=87%) as seen in Figure 10.
FIGURE 10: Incisional hernia at five years
PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analysis include [2-3].
Seroma
A total of 19 studies (PMP - 1290 patients, 127 events; PSC - 1292 patients, 70 events) reported
postoperative seroma details. We accepted the investigators’ definition of seroma. PSC significantly
reduced the incidence of seroma when compared to PMP (OR=1.67 [1.10, 2.55]; p=0.02; I2=19%).
Individual removal of either the Caro-Tarrago, 2019, or Jairam, 2017 study on the leave one out
analysis turned results insignificant.
Upon subgroup analysis, a significant difference was noted between study population subgroups (p-
interaction=0.04; I2=64.5%). PSC had a significantly reduced incidence of seroma in all study
populations except the mixed subgroup (OR=0.47 [0.17, 1.27]; p=0.14; I2=0%).
However, no statistically significant difference was found upon classifying data into: (1) Study design
(p-interaction=0.77; I2=0%), (2) Mesh location (p-interaction=0.29; I 2=20 %), and (3) BMI (p-
interaction=0.26; I2=20.2 %). Forest plots reporting these findings are displayed in Figure 11.
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FIGURE 11: Seroma
(A) Overall analysis; (B) Subgroups by study design; (C) Subgroups by mesh location; (D) Subgroups by
BMI; and (E) Subgroups by population
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PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used the analyses include [1-3,5-6,10-22,25].
Chronic wound pain
Six studies (PMP - 346 patients, 45 events; PSC - 395 patients, 29 events) reported the incidence of
chronic wound pain. The PSC group had significantly reduced chronic wound pain as compared to
PMP (OR=1.71 [1.03, 2.83]; p=0.04; I2=0%). Individual removal of (a) El-Khadrawy, 2009, (b) Muysoms,
2016, (c) Sarr, 2014, and (d) Strzeczyk, 2002, made results insignificant.
Our results were robust and no significant difference among subgroups was found when data was
stratified into: (1) Study design (p-interaction=0.22; I2=32.4%), (2) Mesh location (p-interaction=0.36;
I2=5.9%), (3) BMI (p-interaction=0.29; I2=12.2%), and (4) Study population (p-interaction=0.69;
I2=0%). Figure 12 displays the forest plots of all subgroup analyses for chronic wound pain.
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FIGURE 12: Chronic wound pain
(A) Overall analysis; (B) Subgroups by study design; (C) Subgroups by mesh location; (D) Subgroups by
BMI; and (E) Subgroups by population
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PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in analyses include [1,10-11,18,20,23].
Table 6 reports the subgroup analysis carried out for seroma and chronic wound pain.
Subgroups Seroma Chronic wound pain
 Nstudies
I2
(%)
OR [95% CI] Psubgroup Comments
N
studies
I2
(%)
OR [95% CI] Psubgroup Comments
Study design
RCT 12 10 1.83 [1.15,2.91]
0.77 No Sig.Diff.
5 0 1.63 [0.98, 2.71]
0.22 No Sig.Diff.
Observational 7 37 1.57 [0.63,3.92] 1 -
12.65 [0.48,
331.08]
Mesh location
Onlay 9 40 1.85 [0.89,3.87]
0.29 No Sig.Diff.
2 0 7.92 [0.85, 73.96]
0.36 No Sig.Diff.
Retrorectus 4 0 1.43 [0.74,2.78] 1 - 1.04 [0.06, 16.98]
Preperitoneal 4 40 2.88 [0.94,8.84] 2 0 1.83 [1.03, 3.28]
Intraperitoneal 2 0 0.57 [0.16,2.07] 1 - 0.86 [0.25, 2.94]
Mean BMI
<40 7 16 1.23 [0.59,2.57]
0.26 No Sig.Diff.
2 0 0.88 [0.29, 2.73]
0.29 No Sig.Diff.
>40 7 43 2.31 [1.01,5.28] 2 28 2.38 [0.57, 9.97]
Study population
Bariatric 7 40 2.39 [1.06,5.38]
0.04† Sig. Diff.
3 12 2.34 [0.90, 6.05]
0.69 No Sig.Diff.
Neoplastic 4 0 2.06 [1.06,4.00] 0 - -
Vascular 4 0 2.57 [1.18,5.64] 1 - 1.04 [0.06, 16.98]
Mixed 4 0 0.47 [0.17,1.27] 2 15 1.22 [0.30, 5.00]
TABLE 6: Results of subgroup analyses for seroma and chronic wound pain
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All outcomes are stratified according to study design (RCTs or observational), mesh location (onlay, retrorectus, preperitoneal, and
intraperitoneal), mean BMI (<40 and >40), and study population (bariatric, neoplastic, vascular, and mixed). The value of I2 shows the
heterogeneity among subgroups.
Psubgroup represents p-values between subgroups.
IH, incisional hernia; OR, odds ratio; No Sig. Diff., no significant difference; Sig. Diff, significant difference
†- Significant difference was found between the mixed group with the bariatric (p=0.01), neoplastic (p=0.02), and vascular (p=0.008) groups.
Sensitivity analysis by excluding non-midline incisions and
laparoscopic surgeries
Additional sensitivity analyses were done by excluding studies that employed non-midline incisions
or laparoscopic procedures for outcomes, namely risk of IH at one year and two years, and seroma
(Figure 13). The three-year and five-year follow-up data for IH and chronic wound pain did not
include non-midline incision studies, so they were exempted from this sensitivity analysis. Results did
not differ significantly after sensitivity analysis and PMP was still found to significantly reduce the
risk of IH at the one-year (OR=0.15 [0.03, 0.74]; p=0.02; I2=81%) and two-year (OR=0.25 [0.13, 0.50];
p<0.0001; I2=68%) follow-ups, but it significantly increased the risk of seroma (OR=1.98 [1.24, 3.16];
p=0.004, I2=20%).
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FIGURE 13: Forest plot showing the results of the sensitivity
analysis by excluding non-midline incisions and laparoscopic
surgeries
(A) IH at 1-year; (B) IH at 2-year; and (C) Seroma
IH, incisional hernia; PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence
interval; M-H, Mantel-Haenszel
Other secondary outcomes
No significant difference was seen between the PMP and PSC groups in risk of postoperative
hematoma (OR=1.04 [0.43, 2.50]; p=0.92; I2=0%), surgical site infection (OR=1.09 [0.78, 1.52]; p=0.62;
I2=12%), wound dehiscence (OR=0.69 [0.30, 1.62]; p=0.40; I 2=0%), gastrointestinal complications
(OR=1.40 [0.76, 2.58]; p=0.28; I2=0%), length of hospital stay (WMD=-0.49 [-1.45, 0.47]; p=0.32;
I2=0%), and operating time (WMD=9.18 [-7.17, 25.53]; p=0.27; I 2=80%). The individual forest plots for
all above-mentioned outcomes are given in Figure 14. There was no subgroup difference when all
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secondary outcomes were stratified according to study design as shown in Table 7
FIGURE 14: Forest plot showing results of other secondary
outcomes
2020 Ahmed et al. Cureus 12(9): e10491. DOI 10.7759/cureus.10491 28 of 37
(A) Hematoma; (B) Surgical site infection; (C) Wound dehiscence; (D) Gastrointestinal complications; (E)
Length of hospital stay; and (F) Operating time
PMP, prophylactic mesh placement; PSC, primary suture closure; CI, confidence interval; M-H, Mantel-
Haenszel
Studies used in the analyses include [1-3,5,9-29].
Outcomes
RCT Observational studies
Psubgroups CommentsN
studies
I2
(%)
OR [95% CI] Nstudies
I2
(%)
OR [95% CI]
Hematoma 7 2 0.91 [0.27, 3.07] 3 0 1.21 [0.34, 4.39] 0.75 No Sig. Diff.
Surgical Site Infection 12 25 1.13 [0.74, 1.75] 6 0 0.93 [0.50, 1.72] 0.60 No Sig. Diff.
Wound dehiscence 6 0 0.91 [0.35, 2.36] 2 0 0.25 [0.04, 1.59] 0.22 No Sig. Diff.
Gastrointestinal
complications 6 0 1.52 [0.74, 3.11] 2 0 1.14 [0.35, 3.64] 0.68 No Sig. Diff.
Operating time (minutes) 5 84 16.03 [-6.51,38.56] 3 78
-2.73 [-31.18,
25.73] 0.31 No Sig. Diff.
Length of Hospital stay
(days) 2 0 0.04 [-1.47, 1.55] 5 0 -0.84 [-2.09, 0.40] 0.38 No Sig. Diff.
TABLE 7: Results of subgroup analyses for secondary outcomes
Psubgroup represents p-values between subgroups.
IH, incisional hernia; I2, heterogeneity; OR, odds ratio; CI, confidence interval; No Sig. Diff., no significant difference
Discussion
Our study shows that PMP offers a greater benefit in the prevention of IH than PSC. Mesh placement
showed a reduction in IH risk at intervals of one-year, 18-months, two-years, three-years, and five-
years postoperatively. On subgroup analysis, only study population and mesh location were found to
influence hernia development.
PMP reduced the risk of IH in most populations, with a few exceptions. At an interval of one- and
three-years, the mesh failed at IH prevention in the bariatric group while in the vascular subgroup, the
mesh resulted in being inefficacious at the two-year interval. This was in contrast to the meta-
analyses by Dasari M et al. (bariatric) and Timmermans et al. (abdominal aortic aneurysm) [7,30]. The
exact reason for the difference in findings is unclear, but it was noted that most of the included
studies in the previous meta-analyses had a shorter time interval of six months to one year as
compared to ours, which evaluated for a longer follow-up of two to three years [7,30]. For shorter-
term periods of six months, PMP was inefficacious at IH prevention. Only two studies have inspected
the outcomes at a five-year interval [2-3]. However, to determine the accurate recurrence following IH
repair, we recommend that patients should be followed for a longer period of time (10-15-year follow-
up). 
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Not all mesh locations were effective at IH prevention, and the best effect was observed with onlay
and intraperitoneal mesh placement. The onlay position was superior to intraperitoneal in efficacy
but with higher complication rates. Midline and lateral incisions are best reinforced when onlay mesh
placement is adopted. Though not extensively discussed, some studies hinted at the superior efficacy
of the onlay position [4,8]. The safety and efficacy of mesh type were not extensively studied in our
meta-analysis, as they were beyond the scope of our discussion.
Among the secondary outcomes, only the risk of seroma and chronic wound pain were found to be
significantly increased in the PMP group. Seroma was significantly increased (about two times) in
those with PMP. This concurred with the analysis by Borab et al. and Wang et al. but was contrary to
Timmermans et al., where no such difference was observed [4,7-8]. Upon further subgroup analysis,
only onlay positioning had approximately thrice the risk of seroma development. Borab M et al.
reported that onlay and preperitoneal PMP were linked with a higher risk of seroma development,
which was further aggravated when the PP mesh was placed in the onlay position [4]. This may be
well-explained by the extensive dissection in onlay position, thus increasing the likelihood of
postoperative complications.
Most seroma cases were less morbid and were treated conservatively with antibiotics and
percutaneous drainage. However, some mentioned the removal of mesh due to infection [13,28]. To
decrease seroma incidence, subcutaneous drainage and appropriate tissue management were advised
[6].
Chronic wound pain significantly impacts QoL in patients after any surgical procedure. The degree of
pain is closely associated with the type and extent of surgery, nerve damage, intensity of radio and
chemotherapy, and psychosocial factors. The risk of chronic wound pain with mesh placement is of
much conjecture, as few studies reported a lower incidence of chronic wound pain with mesh use, but
the meta-analysis by Wang et al. found that mesh failed to provide any significant reduction in
chronic wound pain [8]. The results of Wang et al. were limited by a small sample size (3 studies; 229
participants) [8]. Our analysis (6 studies; 741 participants) showed that mesh was associated with a
significantly increased incidence of chronic wound pain compared to suture closure. To quantify the
debilitating burden of chronic pain, few studies included standardized scoring such as visual analog
scale (VAS) for pain and the EQ-5D (EuroQol- 5 Dimension) and SF-36 (36-Item Short Form
Survey) questionnaires for QoL [5,20]. No difference in QoL was found between the mesh and suture
groups [5,20]. Patients in both the PSC and PMP groups suffered from chronic pain, which, however,
was well-tolerated and rarely interfered with routine activities, hence resulting in higher patient
satisfaction [20].
The difference in other secondary outcomes was non-significant. SSI, an infrequent complication in
mesh hernioplasties, is influenced by certain risk factors such as mesh type, obesity, smoking history,
mean operative time, and degree of emergency [5,16,20,25]. The lack of a significant difference
between PMP and PSC for SSI could be attributed to a few postulates. Firstly, only a few studies
adopted complication assessment protocols and standardized assessment scales to gauge the effect of
PMP on different outcomes and QoL. Secondly, there may be an underestimation of the additional
complications due to underreporting.
No significant difference was observed for the length of hospital stay and mean operative time in our
study, whereas Wang et al. found mesh use to be associated with increased operative time [8]. Though
insignificant, the results showed a trend of reduced length of hospital stay with mesh use but with
increased operative time. Additionally, studies failed to analyze the effect of strenuous activities and
early resumption of work. We excluded ‘reoperation’ and 're-hospitalization' outcomes due to
discrepancies in the defining criteria. 
Strengths, limitations, and future suggestions
To the best of our knowledge, this is the first study to run a follow-up duration-based analysis of IH
and included clinical outcomes in various patient populations.
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This updated analysis has adopted a more integrated, extensive (including both observational studies
and RCTs), and comparative approach to gain better insight into the outcomes. Subgroup analysis for
IH outcomes at different follow-up intervals and other significant outcomes (seroma and chronic
wound pain) may help predict the postoperative outcomes better.
However, some aspects may have been missed owing to insufficient studies, ambiguous reporting, or
the redundancy of the results. There is a lack of universal agreement on the definition of hernia
recurrence and the indications for surgical repair. To establish the long-term viability of mesh, the
effect of materials and techniques on the outcomes needs to be addressed. Furthermore, the efficacy
of mesh type and its location needs to be extensively evaluated.
Since this only catered to elective cases, a comparison analysis between emergency and elective
procedures and among other hernia types is warranted. Additionally, the influence of the surgeon’s
technique and expertise on postoperative outcomes is less frequently addressed and studies should be
carried out to explore this aspect as well. These measures may assist in bridging the major gaps in
clinical practice.
Clinical implications
Mesh placement has proven to be, repeatedly, effective in decreasing the incidence of IH after elective
midline laparotomy and laparoscopy. This stands true for some cases of parastomal hernia and
emergency laparotomy. Even with existing infection, mesh use is associated with better results in
both hernia prevention and in lowering wound morbidity [2,10].
Additionally, the adoption of a benefit vs. risk approach in vulnerable (high-risk) patient populations
may assist in reducing the complications. In one of the included studies by N Argudo et al. (2018), the
selection of patients for mesh placement utilizing an algorithm decreased the recurrence of the
hernia, lowered the number of complications, and saved a considerable cost burden [24]. Therefore, a
standardized approach for mesh placement can assist in lowering the cost burden and in decreasing
the mortality rates.
Conclusions
PMP has been effective in decreasing the recurrence rates of IH for both shorter and longer time
periods. It is, however, associated with an increased incidence of seroma and chronic wound pain. No
significant difference was found between the PMP and PSC groups for hematoma, surgical site
infection, wound dehiscence, gastrointestinal complications, length of hospital stay, and operating
time. The benefits of PMP largely outweigh the risk of complications and is beneficial for high-risk
patient populations. There is a need for trials with extensive follow-up durations of 10-15 years to
study the long-term benefits of mesh, and more studies with uniform reporting criteria are needed for
accurately analyzing chronic wound pain outcomes. Furthermore, studies evaluating the efficacy of
one mesh type over another are warranted.
Appendices
Study, year Diagnosis of IH Meshlocation Mesh material
Suture for closing
aponeurosis
Technique for closing
aponeurosis
Pans, 1998
[9] Physical exam Intraperitoneal Polyglactin Polyglactin -
Strzeczyk,
2002 [10] - Onlay Polypropylene Polypropylene 1 Continuous
Peña, 2003
[11]
Physical exam &
CT scan Onlay Polypropylene Nonabsorbable filament Continuous
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Strzelczyk,
2006 [12]
Ultrasound Retrorectus Polypropylene Polypropylene 2 Continuous
El- Khadrawy,
2009 [1] Ultrasound Preperitoneal Polypropylene Polypropylene 1 Continuous
Bevis, 2010
[13]
Clinical exam or
ultrasound
Preperitoneal
& retrorectus Polypropylene Nonabsorbable filament -
Llaguna, 2011
[14]
Physical exam &
imaging studies Preperitoneal Biologic (Alloderm) Polydioxanone 1 Continuous
Curro, 2012
[15]
Clinical exam or
ultrasound Retrorectus Polypropylene
Polyglactin &
polydiossanone Interrupted
Abo-Ryia,
2013 [16]
Clinical exam or
ultrasound preperitoneal Polypropylene Polypropylene 1 Continuous
Armañanzas,
2014 [17]
Clinical exam or
CT scan intraperitoneal Polypropylene Nonabsorbable polyester -
Sarr, 2014
[18]
Clinical exam &
imaging modality. Preperitoneal Biologic (Surgisis Gold)
Nylon, polypropylene, &
polydioxanone Continuous
Bali, 2015 [19] Clinical exam orCT scan Onlay
Biologic (bovine
pericardium) Polydioxanone 1 loop Continuous
Muysoms,
2016 [20]
Clinical exam,
CT scan, or
Ultrasound
Retrorectus Polypropylene Polydioxanone -
Blázquez,
2016 [21] CT scan Onlay
Propylene polyglycolic
acid Poly 4 hydroxybutyrate 2 layer closure
Jairam, 2017
[5]
Physical exam,
ultrasound, or CT
scan
Onlay &
Retrorectus Polypropylene (Optilene)
Slow absorbable with
loop Continuous
Hoyuela,
2017 [22]
Clinical exam or
CT scan onlay Polypropylene Absorbable monofilament Continuous
Kohler, 2018
[23]
Clinical exam or
imaging studies intraperitoneal
Polypropylene-
polyvinylidene fluoride Slow absorbable Continuous
Argudo, 2018
[24]
Clinical diagnosis
or CT scan Onlay
Low weight, wide pore,
partially absorbable Slowly absorbable Continuous
Pereira, 2018
[25]
Clinical exam or
CT scan Onlay
Polyvinylidenefluoride
mesh
Polydioxanone gauge
loop Continuous
Rhemtulla,
2018 [6] CT scan Onlay Biosynthetic mesh Heavy, slow absorbing
Continuous, accompanied by
short stitch technique with 5-
7mm bites
Glauser, 2019
[2]
Clinical exam or
ultrasound Intraperitoneal
Absorbable Porcine
collagen, polyethylene
glycol, glycerol
Late absorbable
monofilament
polydioxanone loop
suture
Continuous
Caro‑Tarrago,
2019 [3]
Clinical exam or
CT scan Onlay
Polydioxanone loop,
propylene mesh Polydioxanone 1 Continuous
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TABLE 8: Incisional hernia diagnosis and details of mesh, suture, and surgery for included
studies
IH, incisional hernia; CT, computed tomography
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Study, year Sequencegeneration
Allocation
concealment
Blinding of
participants
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
outcome
reporting
Other
sources of
bias
Pans, 1998
[9] Unclear Unclear Unclear Low Low Low Low
Peña, 2003
[11] Unclear Unclear Unclear Unclear Low Low Low
Strzelczyk,
2006 [12] Low High High Low Low Low Low
El- Khadrawy,
2009 [1] Unclear Unclear Unclear Unclear Low Low Low
Bevis, 2010
[13] Low Low High High Low Low Low
Abo-Ryia,
2013 [16] Unclear Unclear Low Low Low Low low
Armañanzas,
2014 [17] Low Low Low Low Low Low Low
Sarr, 2014
[18] Low Low Unclear Unclear Low Low low
Bali, 2015 [19] Low Unclear Unclear Unclear Low Low Low
Muysoms,
2016 [20] Low Low Low High Low Low Low
Jairam, 2017
[5] Low Low Low Low Low Low Low
Kohler, 2018
[23] Low Low Low Low Low Low Low
Glauser, 2019
[2] Low Low Low Low Low Low Low
Caro‑Tarrago,
2019 [3] Low Low Low Low Low Low Low
TABLE 9: Cochrane tool for assessing risk of bias in RCTs
RCTs, randomized controlled trials
Quality assessment of published studies included in the meta-analysis.
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Outcome Leave one out analysis results
IH at 6-months No significant effect
IH at 1-year No significant effect
IH at 18-months Not applicable
IH at 2-year No significant effect
IH at 3-years Sensitivity analysis by excluding individual studies kept results significant and robust. Heterogeneity (p=0.05) turned in-significant (p=0.80) but dropped to 0% after removal of Pans, 1998 study.
IH at 5-year Not applicable
Seroma
Removal of either Caro-Tarrago, 2019 or Jairam, 2017 study turned results insignificant {(OR=1.52 [0.97, 2.37]; p=0.07;
I2= 15%) and (OR=1.55 [0.99, 2.44]; p=0.06; I2= 19%), respectively}.
Hematoma No significant effect
Surgical site
infection No significant effect
Chronic wound
pain Results turned insignificant on individual removal of
 
(a) El-Khadrawy, 2009, (New OR= 1.63 [0.98, 2.72]; p= 0.06; I2=0%)
(b) Muysoms, 2016, (New OR=1.76 [0.99, 3.13]; p=0.06; I2=5%)
(c) Sarr, 2014, and (New OR= 1.83 [0.63, 5.27]; p=0.26; I2= 8%)
(d) Strzeczyk, 2002 (New OR=1.63 [0.98, 2.71]; p=0.06; I2= 0%)
Wound
dehiscence No significant effect
Gastrointestinal
complications No significant effect
Operating time No significant effect
Hospital stay
length No significant effect
TABLE 10: Leave one out sensitivity analysis results for all outcomes
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